ArticleFrontiers in pharmacology2019
Anti-metastatic Properties of Naproxen-HBTA in a Murine Model of Cutaneous Melanoma.
Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 33 citations in OpenAlex.
- Hydrogen Sulfide Metabolism in the Skin: From Physiology to Malignancy.International journal of molecular sciences · 2025Review
- Non-steroidal anti-inflammatory drugs conjugated to a synthetic peptide exhibitRSC medicinal chemistry · 2025Article
- Repurposing of Indomethacin and Naproxen as anticancer agents: progress from 2017 to present.RSC advances · 2024Review
- Pills of Multi-Target HInternational journal of molecular sciences · 2024Review
- Investigation of Gold Nanoparticle Naproxen-Derived Conjugations in Ovarian Cancer.ACS materials Au · 2023Article
- Plants and Mushrooms as Possible New Sources of HInternational journal of molecular sciences · 2023Review
- Comparative Study of Different HAntioxidants (Basel, Switzerland) · 2023Article
- Prednisone-hydrogen sulfide releasing hybrid shows improved therapeutic profile in asthma.Frontiers in pharmacology · 2023Article
- Antiproliferative and Proapoptotic Effects of Erucin, a Diet-Derived HAntioxidants (Basel, Switzerland) · 2022Article
- Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and HInternational journal of molecular sciences · 2022Article
- Hydrogen Sulfide Suppresses Skin Fibroblast ProliferationOxidative medicine and cellular longevity · 2022Article
- HJournal of advanced research · 2022Article
- HBiomolecules · 2021Review
- Trends in HAntioxidants (Basel, Switzerland) · 2021Review
- Hydrogen sulfide: Recent progress and perspectives for the treatment of dermatological diseases.Journal of advanced research · 2021Review
- Hydrogen Sulfide in Skin Diseases: A Novel Mediator and Therapeutic Target.Oxidative medicine and cellular longevity · 2021Review
- Role of hydrogen sulfide in endothelial dysfunction: Pathophysiology and therapeutic approaches.Journal of advanced research · 2021Review
- Structure-activity relationships study of isothiocyanates for HJournal of advanced research · 2021Review
- Hydrogen sulfide and dermatological diseases.British journal of pharmacology · 2020Review
Corrections and comments
- Erratum issued
Authors and funding
13 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The beneficial effects of H
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.